20 years ago, the University of Wisconsin broke new ground by isolating the world’s first embryonic stem cells, fueling global research for generations to come. Today, they remain at the forefront of the field, training the next generation of stem cell researchers who will shape medical breakthroughs for generations more.
News
UW–Madison Four-Part Video Series on Stem Cells
Today we bring you the first in a series of four videos about stem cell research here at UW–Madison: how it started, what it’s achieved, and where it’s headed.
FCDI to build $21M stem cell production facility in Madison
Fujifilm Cellular Dynamics Inc. (FCDI) plans to invest $21 million to create a facility in Madison for manufacturing stem cell therapies that can be used as regenerative medicine — cells that can repair or rebuild a patient’s diseased or damaged tissue.
First Carbone Cancer Center patient receives experimental therapy to prevent infections during chemotherapy
Peiman Hematti, MD, a bone marrow transplant physician at the University of Wisconsin Carbone Cancer Center and director of Clinical Hematopoietic Cell Processing Laboratory, is the site principal investigator for a new clinical trial using …
Murphy’s law: Make materials with biology in mind
As an undergraduate student majoring in physics at Illinois Wesleyan University, William Murphy took exactly one biology course: Biology 101. Two decades later, he’s built a career around creating what he calls “bio-inspired” materials such as tissues for drug modeling and bone regeneration. Murphy, the Harvey D. Spangler Professor of biomedical engineering and orthopedics at the University of Wisconsin-Madison, looks to nature for insights on his designs.
New gene editing tool drives stem cell services and discovery
At just two-and-a-half years old, the University of Wisconsin–Madison Human Stem Cell Gene Editing Service is already contemplating expansion. The increased demand has tracked the growth of research projects on campus using a new gene …
Ethan Lippmann wins inaugural $2.5M Chan Zuckerberg Initiative grant for neurodegenerative disorders research
Ethan Lippmann, assistant professor of chemical and biomolecular engineering at Vanderbilt University, has won an inaugural Chan Zuckerberg Initiative grant for neurodegenerative disorders research. The five-year, $2.5 million award supports his goal of better understanding …
Sisters pioneer new kidney transplant at UW that includes immune system
An article in the Wisconsin State Journal described the first combined kidney and hematopoietic stem cell transplant at UW-Madison. Members of the multidisciplinary team that made the breakthrough possible included SCRMC member Peiman Hematti, MD, professor, Hematology, Medical Oncology and Palliative Care, as well as Kristi Schneider, APRN-BC, APNP, director of transplant clinical trials, Department of Surgery, Robert Redfield III, MD, assistant professor, Department of Surgery, and Kristin Bradley, MD, associate professor, Department of Human Oncology.
Biomanufacturing projects stepping out at UW-Madison
A series of projects aimed at advancing the human-health and economic impact of biomanufacturing is already benefiting from a new University of Wisconsin–Madison institute aimed at making the state a Midwestern hub of the ongoing merger of pharmaceuticals, medical devices and cutting-edge tissue engineering. The Forward BIO Institute, announced last month, intends to accelerate UW–Madison’s existing expertise in the next wave of biomedicine. Former SCRMC Co-Director, William Murphy, a professor of biomedical engineering and orthopedics at UW–Madison, directs the Institute.
Five questions with Su-Chun Zhang, forger of brain cells
Su-Chun Zhang, a Waisman Center researcher and UW School of Medicine and Public Health professor of neurology and neuroscience, was the first in the world to craft human brain cells from human embryonic stem (ES) cells, and later from the related induced pluripotent (iPS) cells. In light of the 20th anniversary of James Thomson’s derivation of human ES cells, we had some questions for a founder of stem cell neuroscience